Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immunome Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 30 | −5 |
| Shares | 2.39M | 2.79M | +399.5K (+16.7%) |
| Value | $58.3M | $36.4M | −$22.0M (−37.6%) |
New holders (5)
Institutions that held Immunome Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atom Investors LP | 45,858 | $594.0K | 0.16% |
| Bank of America Corp | 6,244 | $81.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 926 | $12.0K | 0.00% |
| Massmutual Trust Co FSB | 514 | $7.00K | 0.00% |
| Newbridge Financial Services Group, Inc. | 375 | $5.00K | 0.00% |
Sold out (10)
Institutions that held Immunome Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 21,089 | $514.0K |
| HAP Trading, LLC | 17,922 | $436.0K |
| Virtu Financial LLC | 10,904 | $266.0K |
| Price T Rowe Associates Inc | 10,800 | $263.0K |
| Baldwin Investment Management, LLC | 9,196 | $224.0K |
| Lindbrook Capital, LLC | 1,000 | $24.0K |
| Cutler Group LP | 719 | $17.0K |
| US Bancorp | 112 | $3.00K |
| Advisor Group Holdings, Inc. | 100 | $2.00K |
| FMR LLC | 32 | $1.00K |